Cached score snapshot

US.SOLV · Solventum

110分制 54.9/110；5D動能v2 15/50；排序分 69.9/160

Back to ranking Open volume snapshot

Ranking score 69.9/160

Main score 54.9/110

5D momentum v2 15/50

Rank #76

Setup grade F 32.2

Score breakdown

避免

Medium twelvedata

Score and price trend

F 32.2 Low sample confidence

Main score, 5D momentum v2, close price, and improving or exit-review turn signals are plotted from archived daily snapshots.

Move the mouse over the chart lines to inspect readings.

**Historical projection**
Model	Median	P25/P75	歷史相似情境上漲比例	Down5	Actual / compare
Rolling DOE best · score 2.31 · anchors 120	+0.71%	-0.92% / +2.33%	58.8%	1.3%	Actual outcome pending · 0 / 3 bars observed
30D observation	+5.86%	-2.53% / +11.97%	67.5%	15%	Actual outcome pending · 0 / 30 bars observed
Historical projection 10D n=160	+0.40%	-1.70% / +2.35%	54.4%	3.8%	Actual outcome pending · 0 / 10 bars observed

歷史情境統計基於已存檔相似 setup；圖中投影中位線為統計中位數的線性插值展示，並非價格路徑預測或買賣建議。

2026-06-25 → 2026-10-30 · 120 archived points · 1 Improving turn signal · 8 Deteriorating signal

Summary

score_with_momentum_v2 = main score + 5D momentum v2

Ranking score 69.9

Display grade 避免

Model version cursor_18_27_news_v2_160

Main score 54.9/110 (避免)

5D momentum v2 15/50 (弱)

Score with momentum v2 69.9/160 (低排序)

Risk level Medium

Audit trace

Full calculation detail

Calculation detail · 8 sections

Market inputs

Bar count 60

ma20 90.2185

ma50 86.082

close 88.84

prevClose 87.53

avgVolume20 967049

volumeRatio 2.4

changePercent 1.5

Metrics snapshot

close 88.84

volume 2316482

changePercent 1.5

110-point main rating

基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10

Main score 54.9/110

Main rating 避免

5D momentum v2 15/50

Score with momentum v2 69.9/160

Formula score_with_momentum_v2 = main_score + momentum_5d_v2_score

基本面 — 3.4/5 · 一般

Dimension score 3.4/5

Dimension grade 一般

Sub-items

pbPoints 0.4

pePoints 0.5

epsPoints 0

roePoints 0.75

debtPoints 0.4

marginPoints 0.4

turnoverUsdM 205.7963

volumePoints 0.5

revenuePoints 0

dividendPoints 0

marketCapPoints 0.4

資金流 — 6.8/20 · 較差

Dimension score 6.8/20

Dimension grade 較差

Sub-items

cmfPoints 0.8

mfiPoints 2.4

obvPoints 0.8

vwapPoints 0.8

institutional

score 2

details

source optional-neutral

warning

code INSTITUTIONAL_DATA_OPTIONAL

symbol US.SOLV

message Institutional ownership is unavailable; neutral 2/4 money-flow treatment used.

optional true

holderCount n/a

holderPoints 2

top10ShareRatio n/a

concentrationPenalty 0

institutionPoints 2

市場環境 — 9.6/15 · 一般

Dimension score 9.6/15

Dimension grade 一般

Sub-items

vix

score 2.4

details

source twelvedata+fred

vixClose 15.44

trend

score 3.4

details

qqq

ma20 713.2355

ma50 709.9512

name QQQ

close 721.45

points 2

spy

ma20 764.3035

ma50 759.731

name SPY

close 761.69

points 1.4

source twelvedata+fred

atrPct 2.6215

atrPoints 3

cciPoints 0.8

vixPoints 2.4

marketTrendPoints 3.4

催化劑 — 6/20 · 較差

Dimension score 6/20

Dimension grade 較差

Sub-items

catalyst

score 6

details

source finnhub_news_keyword_model

articleCount 7

catalystCount 1

catalystPoints 6

風險管理 — 6.6/10 · 一般

Dimension score 6.6/10

Dimension grade 一般

Sub-items

position

score 1.4

details

atrPct 2.6215

turnoverUsdM 205.7963

liquidityPoints 0.4

volatilityPoints 1

rrPoints 1.4

stopLevels

symbol US.SOLV

rr_range 1:1.0-1:2.5

risk_profile 中等

stop_loss_price 84.1822

strength_details

ma_score 1.5

atr_score 2

rsi_score 1

macd_score 1.5

volume_score 3

market_adjustment 1

risk_reward_ratio 1.1

stop_loss_percent 5.2

take_profit_price 94.0761

target_multiplier 1.9

technical_strength 1.78

take_profit_percent 5.9

positionPoints 1.4

stopLossPoints 1.8

diversification

score 2

details

method sector concentration proxy; no portfolio holdings used

sector Health Care

concentratedSectorPenalty 0

riskRewardRatio 1.2

stopLossPercent 5.2429

diversificationPoints 2

技術信號 — 18.5/30 · 一般

Dimension score 18.5/30

Dimension grade 一般

Sub-items

bbPoints 2.4

adxPoints 3

sarPoints 1.2

vcpPoints 1

macdPoints 2.4

vcpPayload

vcp_pass false

vcp_score 1

vcp_reason 跌縮量(近10日5日)；站上MA50；Ready=N；Confirm=N

vcp_metrics

up_days 2

vol_ref 1019403.3333

down_days 7

vcp_ready false

above_ma50 true

avg_vol_10 865590

avg_vol_20 891480

avg_vol_30 1019403.3333

range_pct_10 0.0841

range_pct_20 0.0845

range_pct_30 0.1457

up_expand_ok false

lookback_used 59

near_20d_high true

contraction_ok false

down_shrink_ok true

up_expand_days 1

breakout_20d_ok false

vol_ratio_10_30 0.8491

dist_to_20d_high 0.0565

down_shrink_days 5

breakout_level_20d 94.16

vcp_breakout_confirm false

contraction_ratio_10_30 0.5773

vcp_name_en Volatility Contraction Pattern

vcp_name_zh 波動收縮形態

vol_contraction false

kdjAdxPoints 0.7

rsiKdjPoints 2.4

volumeWeight 2

maCrossPoints 1.6

shortRsiPoints 0.8

shortMacdPoints 0.4

volConfirmPoints 1

volumePointsTechnical 1.6

情緒分析 — 4/10 · 較差

Dimension score 4/10

Dimension grade 較差

Sub-items

sentiment

score 4

details

source finnhub_news_keyword_model

articleCount 7

negativeHits 0

positiveHits 2

sentimentScoreRaw 0.7

sentimentData

raw {"id":142223244,"url":"https://finnhub.io/api/news?id=59633399520a47eacff7f99436994f965caf02cf678587f2923d18419da155f7","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"Earlier this quarter, Solventum reported results that surpassed analyst expectations, with both organic revenue and EPS beating estimates and management emphasizing strong execution and ongoing transformation efforts. An interesting angle is how Solventum’s exposure to surgical equipment and consumables, including AI and robotics-enabled solutions, supports relatively consistent procedural demand and innovation-driven opportunities. Now we’ll explore how this stronger-than-expected quarter,...","category":"company","datetime":1789625565,"headline":"What Solventum (SOLV)'s Earnings Beat and Surgical AI Push Means For Shareholders"}, {"id":142198487,"url":"https://finnhub.io/api/news?id=05a6bd6f2bd1d52654aa9e5f44225f78f2e05bf22c065fd021b67ffb8936e3c4","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at surgical equipment & consumables - diversified stocks, starting with Solventum (NYSE:SOLV).","category":"company","datetime":1789577572,"headline":"Q2 Surgical Equipment & Consumables - Diversified Earnings: Solventum (NYSE:SOLV) Impresses"}, {"id":142026578,"url":"https://finnhub.io/api/news?id=2931480ce1f7410699e9456064602e1ff2219f424fb1a9679dc6be5352820152","image":"https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png","source":"SeekingAlpha","related":"SOLV","summary":"Solventum Corporation (SOLV) Wells Fargo 21st Annual Healthcare Conference September 9, 2026 10:15 AM EDTCompany ParticipantsBryan Hanson - CEO &...","category":"company","datetime":1788958625,"headline":"Solventum Corporation (SOLV) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript"}, {"id":141438444,"url":"https://finnhub.io/api/news?id=77e475d6daad55e35ae6daf27ae9ec6f3b1eaf004c16965e49f4c51a2f15d3c5","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"Solventum (SOLV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.","category":"company","datetime":1788535819,"headline":"Solventum (SOLV) Up 11.4% Since Last Earnings Report: Can It Continue?"}, {"id":141379899,"url":"https://finnhub.io/api/news?id=cb518bc241fbc181265dbe9baa6adab575978b2b899e2700b505d6a6bba4958e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"Solventum's growth, higher earnings outlook and cost cuts strengthen its case, but heavy debt and 2027 margin risks temper the upside.","category":"company","datetime":1788375240,"headline":"Should Investors Buy SOLV as Growth Improves but Debt Risks Persist?"}, {"id":141339718,"url":"https://finnhub.io/api/news?id=26071c76c25a1bdffce7a09020cca095f0cfc5a5dbc5292e3e031d35f82698d9","image":"","source":"Fintel","related":"SOLV","summary":"","category":"company","datetime":1787947900,"headline":"Solventum (SOLV) Price Target Increased by 10.88% to 95.90"}, {"id":141365587,"url":"https://finnhub.io/api/news?id=68ec63ea3407f00b7c5c4073a7a1c3cac4476c335afebb635ba07c026deeacd4","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"Solventum’s 22% return over the past six months has outpaced the S&P 500 by 10.4%, and its stock price has climbed to $89.05 per share. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.","category":"company","datetime":1787938372,"headline":"3 Reasons to Avoid SOLV and 1 Stock to Buy Instead"}

raw_source {"id":142252751,"url":"https://finnhub.io/api/news?id=8dffac6f353cafa877be7a43649e86347a4a64618a16a41f9143e33d6c293069","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1304057123/image_1304057123.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"SOLV","summary":"Solventum trades at a significant discount to medical technology peers, with a forward P/E of ~13x and suppressed EV/EBITDA multiples. Learn more about SOLV stock here.","category":"company","datetime":1789717319,"headline":"Solventum: Divestiture Unlocking Upside In A Spinoff Revaluation Play"}, {"id":142231517,"url":"https://finnhub.io/api/news?id=d2fbcf5a6ad084f6029a82395e4b80e290f082b45503961eff049d8b5a9b6b6c","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"SOLV's strong Q2 performance, growth investments and cost-saving program support its outlook, though higher raw material costs remain a concern.","category":"company","datetime":1789660260,"headline":"Here's Why You Should Hold Solventum Stock in Your Portfolio for Now"}, {"id":142223244,"url":"https://finnhub.io/api/news?id=59633399520a47eacff7f99436994f965caf02cf678587f2923d18419da155f7","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"Earlier this quarter, Solventum reported results that surpassed analyst expectations, with both organic revenue and EPS beating estimates and management emphasizing strong execution and ongoing transformation efforts. An interesting angle is how Solventum’s exposure to surgical equipment and consumables, including AI and robotics-enabled solutions, supports relatively consistent procedural demand and innovation-driven opportunities. Now we’ll explore how this stronger-than-expected quarter,...","category":"company","datetime":1789625565,"headline":"What Solventum (SOLV)'s Earnings Beat and Surgical AI Push Means For Shareholders"}, {"id":142198487,"url":"https://finnhub.io/api/news?id=05a6bd6f2bd1d52654aa9e5f44225f78f2e05bf22c065fd021b67ffb8936e3c4","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at surgical equipment & consumables - diversified stocks, starting with Solventum (NYSE:SOLV).","category":"company","datetime":1789577572,"headline":"Q2 Surgical Equipment & Consumables - Diversified Earnings: Solventum (NYSE:SOLV) Impresses"}, {"id":142138123,"url":"https://finnhub.io/api/news?id=996fef6f894db5de5b3f7384dca6b49a263730212beb8addd07e9b0e2bdef5ff","image":"","source":"Benzinga","related":"SOLV","summary":"BTIG analyst Ryan Zimmerman reiterates Solventum (NYSE:SOLV) with a Buy and maintains $95 price target.","category":"company","datetime":1789367355,"headline":"BTIG Reiterates Buy on Solventum, Maintains $95 Price Target"}, {"id":142025907,"url":"https://finnhub.io/api/news?id=907ee1885f7be1df8b9cc9496a9dd6e035c78965016b6901e42093328482cfc9","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant challenges, whether it’s stagnating growth, heavy debt, or disruptive new competitors.","category":"company","datetime":1788966878,"headline":"3 S&P 500 Stocks with Open Questions"}, {"id":142026578,"url":"https://finnhub.io/api/news?id=2931480ce1f7410699e9456064602e1ff2219f424fb1a9679dc6be5352820152","image":"https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png","source":"SeekingAlpha","related":"SOLV","summary":"Solventum Corporation (SOLV) Wells Fargo 21st Annual Healthcare Conference September 9, 2026 10:15 AM EDTCompany ParticipantsBryan Hanson - CEO &...","category":"company","datetime":1788958625,"headline":"Solventum Corporation (SOLV) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript"}, {"id":141438444,"url":"https://finnhub.io/api/news?id=77e475d6daad55e35ae6daf27ae9ec6f3b1eaf004c16965e49f4c51a2f15d3c5","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"Solventum (SOLV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.","category":"company","datetime":1788535819,"headline":"Solventum (SOLV) Up 11.4% Since Last Earnings Report: Can It Continue?"}, {"id":141389683,"url":"https://finnhub.io/api/news?id=8bcc4d32667b76be3a5f2396ca65a345fbe62348b68063d767e0d78ef2844e12","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"Solventum (NYSE: SOLV) announced today that management will participate in a fireside chat at the Wells Fargo Healthcare Conference on Wednesday, Sept. 9, 2026, beginning at approximately 10:15 a.m. EDT in Boston, MA.","category":"company","datetime":1788379500,"headline":"Solventum to Participate in the 2026 Wells Fargo Healthcare Conference"}, {"id":141379899,"url":"https://finnhub.io/api/news?id=cb518bc241fbc181265dbe9baa6adab575978b2b899e2700b505d6a6bba4958e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"Solventum's growth, higher earnings outlook and cost cuts strengthen its case, but heavy debt and 2027 margin risks temper the upside.","category":"company","datetime":1788375240,"headline":"Should Investors Buy SOLV as Growth Improves but Debt Risks Persist?"}, {"id":141339718,"url":"https://finnhub.io/api/news?id=26071c76c25a1bdffce7a09020cca095f0cfc5a5dbc5292e3e031d35f82698d9","image":"","source":"Fintel","related":"SOLV","summary":"","category":"company","datetime":1787947900,"headline":"Solventum (SOLV) Price Target Increased by 10.88% to 95.90"}, {"id":141365587,"url":"https://finnhub.io/api/news?id=68ec63ea3407f00b7c5c4073a7a1c3cac4476c335afebb635ba07c026deeacd4","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"Solventum’s 22% return over the past six months has outpaced the S&P 500 by 10.4%, and its stock price has climbed to $89.05 per share. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.","category":"company","datetime":1787938372,"headline":"3 Reasons to Avoid SOLV and 1 Stock to Buy Instead"}, {"id":141365430,"url":"https://finnhub.io/api/news?id=61a03b449d5a885e39b6dbcae3a9e72871ea186a8e8c5a222ce1430ced2b10dc","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are usually cheap for a reason, and a low valuation can reflect underlying business challenges rather than a genuine bargain.","category":"company","datetime":1787923492,"headline":"3 Value Stocks with Open Questions"}, {"id":141314075,"url":"https://finnhub.io/api/news?id=cffee9de1f9c3c33dbc7f50b1cfc92908d0a7791b14fc63ba2cec5a04d3d6cb8","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1285071364/image_1285071364.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"SOLV","summary":"Embecta (EMBC) looks like a deep value buy: P/E under 3x, 50%+ FCF yield, insider buying and rebound setup.","category":"company","datetime":1787613074,"headline":"The Bottom Fishing Club - Embecta: Excellent Turnaround Prospect In Defensive Medical Products"}, {"id":141285779,"url":"https://finnhub.io/api/news?id=7c86e597ea1845610c6ae5afb3837269e13b54c7d0a294610c15eef5e61e207f","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have returned 27.5% over the past six months, topping the S&P 500 by 16.2 percentage points.","category":"company","datetime":1787234355,"headline":"1 Healthcare Stock for Long-Term Investors and 2 Facing Challenges"}

data_source finnhub_news_keyword_model

article_count 7

negative_hits 0

positive_hits 2

recomputed_at_score true

sentiment_score_raw 0.7

source_article_count 15

discarded_article_count 8

sentimentPoints 4

Dimension contribution

Dimension Raw Max Norm % Contrib

基本面 3.4 5/110 68% 3.4

資金流 6.8 20/110 34% 6.8

市場環境 9.6 15/110 64% 9.6

催化劑 6 20/110 30% 6

風險管理 6.6 10/110 66% 6.6

技術信號 18.5 30/110 61.67% 18.5

情緒分析 4 10/110 40% 4

5D momentum v2 breakdown

Cursor_18.25 5D momentum v2 0-50

5D momentum v2 15/50

ret_5d 0.0159

max_score 50

max_total 50

raw_total 15

vcp_bonus 0

vol_ratio 2.5985

ret_points 4

vol_points 8

range_ratio 1.471

volat_points 2

day_range_pct 0.0338

model_version cursor_18_27_news_v2_160

available_bars 30

breakout_points 0

partial_history false

pullback_points 1

breakout_vol_bonus 0

first_breakout_20d false

return_window_days 5

first_breakout_bonus 0

breakout_quality_points 0

Risk management

level Medium

reason risk management score >= 6.5/10

position

score 1.4

details

atrPct 2.6215

turnoverUsdM 205.7963

liquidityPoints 0.4

volatilityPoints 1

rrPoints 1.4

stopLevels

symbol US.SOLV

rr_range 1:1.0-1:2.5

risk_profile 中等

stop_loss_price 84.1822

strength_details

ma_score 1.5

atr_score 2

rsi_score 1

macd_score 1.5

volume_score 3

market_adjustment 1

risk_reward_ratio 1.1

stop_loss_percent 5.2

take_profit_price 94.0761

target_multiplier 1.9

technical_strength 1.78

take_profit_percent 5.9

positionPoints 1.4

stopLossPoints 1.8

diversification

score 2

details

method sector concentration proxy; no portfolio holdings used

sector Health Care

concentratedSectorPenalty 0

riskRewardRatio 1.2

stopLossPercent 5.2429

diversificationPoints 2

Calculation audit log

基本面分析總分: 3.4/5分
資金流分析總分: 6.8/20分
市場環境分析總分: 9.6/15分
催化劑分析: 6/20分
風險管理總分: 6.6/10分
技術信號分析總分: 18.5/30分
情緒分析: 4/10分
共振率(僅顯示不加分): 0%

Technical indicators

adx

value 85.71

atr

atr 2.3289

rule ATR / current price; lower volatility scores higher

score 6

atr_pct 2.62

cci

rule Cursor_18.24 CCI bands

level 超買或超賣風險

score 2

value -108.54

cmf

rule Cursor_18.24 CMF bands

level 派發

score 2

value -0.0308

kdj

d 31.34

j 33.98

k 32.22

rule Cursor_18.24 K/D cross

score 4

signal 金叉

mfi

rule Cursor_18.24 MFI bands

level 平衡

score 6

value 50.24

obv

rule Cursor_18.24 recent_slope vs previous_slope

score 2

trend 資金流出

value 2257082

recentSlope -121401.8

previousSlope 15980

rsi

value 41.3

sar

rule Cursor_18.24 Parabolic SAR

score 4

trend 下降

value 91.8936

position SAR喺價上

distancePct 3.44

previousTrend 下降

ma50

value 86.082

macd

macd 0.5667

trend 中性偏多

signal 1.1336

histogram -0.5668

vwap

rule Cursor_18.24 VWAP 20D consecutive close

score 2

value 90.1643

position <VWAP

consecutiveAbove 0

volume

rule Cursor_18.24 volume ratio

level 量價配合

ratio 2.4

score 8

avgVolume 967049

currentVolume 2316482

derived

ma20 90.2185

ma50 86.082

prevClose 87.53

avgVolume10 1018808

avgVolume20 967049

changePercent 1.5

avgVolumeForScore 967049

ma_cross

ma20 90.2185

ma50 86.082

rule Cursor_18.24 MA20/MA50 cross

cross 多頭

score 4

prevMa20 90.207

prevMa50 85.8244

spreadPct 4.81

isVolumeBreakout true

bollinger

lower 87.2798

upper 93.1572

position 中間

rsi_short

value 58.95

macd_short

macd 0

trend 中性

signal 0

histogram 0

volume_ratio

ratio 2.4

Raw calculation JSON

{
  "risk": {
    "level": "Medium",
    "reason": "risk management score >= 6.5/10",
    "position": {
      "score": 1.4,
      "details": {
        "atrPct": 2.6214542998649257,
        "turnoverUsdM": 205.79626088,
        "liquidityPoints": 0.4,
        "volatilityPoints": 1
      }
    },
    "rrPoints": 1.4,
    "stopLevels": {
      "symbol": "US.SOLV",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 84.1822,
      "strength_details": {
        "ma_score": 1.5,
        "atr_score": 2,
        "rsi_score": 1,
        "macd_score": 1.5,
        "volume_score": 3
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1.1,
      "stop_loss_percent": 5.2,
      "take_profit_price": 94.0761,
      "target_multiplier": 1.9,
      "technical_strength": 1.78,
      "take_profit_percent": 5.9
    },
    "positionPoints": 1.4,
    "stopLossPoints": 1.8,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.2,
    "stopLossPercent": 5.2429085997298515,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 69.9,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 54.9,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 15
  },
  "market": {
    "ma20": 90.2185,
    "ma50": 86.082,
    "close": 88.84,
    "prevClose": 87.53,
    "avgVolume20": 967049,
    "volumeRatio": 2.4,
    "changePercent": 1.5
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 15,
    "details": {
      "ret_5d": 0.015894797026872576,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 15,
      "vcp_bonus": 0,
      "vol_ratio": 2.5984677166060934,
      "ret_points": 4,
      "vol_points": 8,
      "range_ratio": 1.470999310124681,
      "volat_points": 2,
      "day_range_pct": 0.03376857271499324,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 1,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 69.9,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 3.4,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 68,
        "contribution": 3.4
      },
      {
        "raw": 6.8,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 34,
        "contribution": 6.8
      },
      {
        "raw": 9.6,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 64,
        "contribution": 9.6
      },
      {
        "raw": 6,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 30,
        "contribution": 6
      },
      {
        "raw": 6.6,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 66,
        "contribution": 6.6
      },
      {
        "raw": 18.5,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 61.67,
        "contribution": 18.5
      },
      {
        "raw": 4,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 40,
        "contribution": 4
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "checked",
  "standard110": {
    "rating": "避免",
    "result": 54.9,
    "details": [
      "基本面分析總分: 3.4/5分",
      "資金流分析總分: 6.8/20分",
      "市場環境分析總分: 9.6/15分",
      "催化劑分析: 6/20分",
      "風險管理總分: 6.6/10分",
      "技術信號分析總分: 18.5/30分",
      "情緒分析: 4/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 6,
      "基本面": 3.4,
      "資金流": 6.8,
      "市場環境": 9.6,
      "情緒分析": 4,
      "技術信號": 18.5,
      "風險管理": 6.6
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 6,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 7,
              "catalystCount": 1
            }
          },
          "catalystPoints": 6
        }
      },
      "基本面": {
        "max": 5,
        "grade": "一般",
        "items": {
          "pbPoints": 0.4,
          "pePoints": 0.5,
          "epsPoints": 0,
          "roePoints": 0.75,
          "debtPoints": 0.4,
          "marginPoints": 0.4,
          "turnoverUsdM": 205.79626088,
          "volumePoints": 0.5,
          "revenuePoints": 0,
          "dividendPoints": 0,
          "marketCapPoints": 0.4
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "較差",
        "items": {
          "cmfPoints": 0.8,
          "mfiPoints": 2.4,
          "obvPoints": 0.8,
          "vwapPoints": 0.8,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.SOLV",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "一般",
        "items": {
          "vix": {
            "score": 2.4,
            "details": {
              "source": "twelvedata+fred",
              "vixClose": 15.44
            }
          },
          "trend": {
            "score": 3.4,
            "details": {
              "qqq": {
                "ma20": 713.2354945,
                "ma50": 709.9511974999997,
                "name": "QQQ",
                "close": 721.45001,
                "points": 2
              },
              "spy": {
                "ma20": 764.3034934499999,
                "ma50": 759.73099818,
                "name": "SPY",
                "close": 761.69,
                "points": 1.4
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 2.6214542998649257,
          "atrPoints": 3,
          "cciPoints": 0.8,
          "vixPoints": 2.4,
          "marketTrendPoints": 3.4
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "較差",
        "items": {
          "sentiment": {
            "score": 4,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 7,
              "negativeHits": 0,
              "positiveHits": 2,
              "sentimentScoreRaw": 0.7
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 142223244,
                "url": "https://finnhub.io/api/news?id=59633399520a47eacff7f99436994f965caf02cf678587f2923d18419da155f7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "Earlier this quarter, Solventum reported results that surpassed analyst expectations, with both organic revenue and EPS beating estimates and management emphasizing strong execution and ongoing transformation efforts. An interesting angle is how Solventum’s exposure to surgical equipment and consumables, including AI and robotics-enabled solutions, supports relatively consistent procedural demand and innovation-driven opportunities. Now we’ll explore how this stronger-than-expected quarter,...",
                "category": "company",
                "datetime": 1789625565,
                "headline": "What Solventum (SOLV)'s Earnings Beat and Surgical AI Push Means For Shareholders"
              },
              {
                "id": 142198487,
                "url": "https://finnhub.io/api/news?id=05a6bd6f2bd1d52654aa9e5f44225f78f2e05bf22c065fd021b67ffb8936e3c4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at surgical equipment & consumables - diversified stocks, starting with Solventum (NYSE:SOLV).",
                "category": "company",
                "datetime": 1789577572,
                "headline": "Q2 Surgical Equipment & Consumables - Diversified Earnings: Solventum (NYSE:SOLV) Impresses"
              },
              {
                "id": 142026578,
                "url": "https://finnhub.io/api/news?id=2931480ce1f7410699e9456064602e1ff2219f424fb1a9679dc6be5352820152",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "SOLV",
                "summary": "Solventum Corporation (SOLV) Wells Fargo 21st Annual Healthcare Conference September 9, 2026 10:15 AM EDTCompany ParticipantsBryan Hanson - CEO &...",
                "category": "company",
                "datetime": 1788958625,
                "headline": "Solventum Corporation (SOLV) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript"
              },
              {
                "id": 141438444,
                "url": "https://finnhub.io/api/news?id=77e475d6daad55e35ae6daf27ae9ec6f3b1eaf004c16965e49f4c51a2f15d3c5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "Solventum (SOLV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
                "category": "company",
                "datetime": 1788535819,
                "headline": "Solventum (SOLV) Up 11.4% Since Last Earnings Report: Can It Continue?"
              },
              {
                "id": 141379899,
                "url": "https://finnhub.io/api/news?id=cb518bc241fbc181265dbe9baa6adab575978b2b899e2700b505d6a6bba4958e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "Solventum's growth, higher earnings outlook and cost cuts strengthen its case, but heavy debt and 2027 margin risks temper the upside.",
                "category": "company",
                "datetime": 1788375240,
                "headline": "Should Investors Buy SOLV as Growth Improves but Debt Risks Persist?"
              },
              {
                "id": 141339718,
                "url": "https://finnhub.io/api/news?id=26071c76c25a1bdffce7a09020cca095f0cfc5a5dbc5292e3e031d35f82698d9",
                "image": "",
                "source": "Fintel",
                "related": "SOLV",
                "summary": "",
                "category": "company",
                "datetime": 1787947900,
                "headline": "Solventum (SOLV) Price Target Increased by 10.88% to 95.90"
              },
              {
                "id": 141365587,
                "url": "https://finnhub.io/api/news?id=68ec63ea3407f00b7c5c4073a7a1c3cac4476c335afebb635ba07c026deeacd4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "Solventum’s 22% return over the past six months has outpaced the S&P 500 by 10.4%, and its stock price has climbed to $89.05 per share. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.",
                "category": "company",
                "datetime": 1787938372,
                "headline": "3 Reasons to Avoid SOLV and 1 Stock to Buy Instead"
              }
            ],
            "raw_source": [
              {
                "id": 142252751,
                "url": "https://finnhub.io/api/news?id=8dffac6f353cafa877be7a43649e86347a4a64618a16a41f9143e33d6c293069",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1304057123/image_1304057123.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "SOLV",
                "summary": "Solventum trades at a significant discount to medical technology peers, with a forward P/E of ~13x and suppressed EV/EBITDA multiples. Learn more about SOLV stock here.",
                "category": "company",
                "datetime": 1789717319,
                "headline": "Solventum: Divestiture Unlocking Upside In A Spinoff Revaluation Play"
              },
              {
                "id": 142231517,
                "url": "https://finnhub.io/api/news?id=d2fbcf5a6ad084f6029a82395e4b80e290f082b45503961eff049d8b5a9b6b6c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "SOLV's strong Q2 performance, growth investments and cost-saving program support its outlook, though higher raw material costs remain a concern.",
                "category": "company",
                "datetime": 1789660260,
                "headline": "Here's Why You Should Hold Solventum Stock in Your Portfolio for Now"
              },
              {
                "id": 142223244,
                "url": "https://finnhub.io/api/news?id=59633399520a47eacff7f99436994f965caf02cf678587f2923d18419da155f7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "Earlier this quarter, Solventum reported results that surpassed analyst expectations, with both organic revenue and EPS beating estimates and management emphasizing strong execution and ongoing transformation efforts. An interesting angle is how Solventum’s exposure to surgical equipment and consumables, including AI and robotics-enabled solutions, supports relatively consistent procedural demand and innovation-driven opportunities. Now we’ll explore how this stronger-than-expected quarter,...",
                "category": "company",
                "datetime": 1789625565,
                "headline": "What Solventum (SOLV)'s Earnings Beat and Surgical AI Push Means For Shareholders"
              },
              {
                "id": 142198487,
                "url": "https://finnhub.io/api/news?id=05a6bd6f2bd1d52654aa9e5f44225f78f2e05bf22c065fd021b67ffb8936e3c4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at surgical equipment & consumables - diversified stocks, starting with Solventum (NYSE:SOLV).",
                "category": "company",
                "datetime": 1789577572,
                "headline": "Q2 Surgical Equipment & Consumables - Diversified Earnings: Solventum (NYSE:SOLV) Impresses"
              },
              {
                "id": 142138123,
                "url": "https://finnhub.io/api/news?id=996fef6f894db5de5b3f7384dca6b49a263730212beb8addd07e9b0e2bdef5ff",
                "image": "",
                "source": "Benzinga",
                "related": "SOLV",
                "summary": "BTIG  analyst Ryan Zimmerman   reiterates Solventum (NYSE:SOLV) with a Buy and maintains $95 price target.",
                "category": "company",
                "datetime": 1789367355,
                "headline": "BTIG Reiterates Buy on Solventum, Maintains $95 Price Target"
              },
              {
                "id": 142025907,
                "url": "https://finnhub.io/api/news?id=907ee1885f7be1df8b9cc9496a9dd6e035c78965016b6901e42093328482cfc9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant challenges, whether it’s stagnating growth, heavy debt, or disruptive new competitors.",
                "category": "company",
                "datetime": 1788966878,
                "headline": "3 S&P 500 Stocks with Open Questions"
              },
              {
                "id": 142026578,
                "url": "https://finnhub.io/api/news?id=2931480ce1f7410699e9456064602e1ff2219f424fb1a9679dc6be5352820152",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "SOLV",
                "summary": "Solventum Corporation (SOLV) Wells Fargo 21st Annual Healthcare Conference September 9, 2026 10:15 AM EDTCompany ParticipantsBryan Hanson - CEO &...",
                "category": "company",
                "datetime": 1788958625,
                "headline": "Solventum Corporation (SOLV) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript"
              },
              {
                "id": 141438444,
                "url": "https://finnhub.io/api/news?id=77e475d6daad55e35ae6daf27ae9ec6f3b1eaf004c16965e49f4c51a2f15d3c5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "Solventum (SOLV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
                "category": "company",
                "datetime": 1788535819,
                "headline": "Solventum (SOLV) Up 11.4% Since Last Earnings Report: Can It Continue?"
              },
              {
                "id": 141389683,
                "url": "https://finnhub.io/api/news?id=8bcc4d32667b76be3a5f2396ca65a345fbe62348b68063d767e0d78ef2844e12",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "Solventum (NYSE: SOLV) announced today that management will participate in a fireside chat at the Wells Fargo Healthcare Conference on Wednesday, Sept. 9, 2026, beginning at approximately 10:15 a.m. EDT in Boston, MA.",
                "category": "company",
                "datetime": 1788379500,
                "headline": "Solventum to Participate in the 2026 Wells Fargo Healthcare Conference"
              },
              {
                "id": 141379899,
                "url": "https://finnhub.io/api/news?id=cb518bc241fbc181265dbe9baa6adab575978b2b899e2700b505d6a6bba4958e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "Solventum's growth, higher earnings outlook and cost cuts strengthen its case, but heavy debt and 2027 margin risks temper the upside.",
                "category": "company",
                "datetime": 1788375240,
                "headline": "Should Investors Buy SOLV as Growth Improves but Debt Risks Persist?"
              },
              {
                "id": 141339718,
                "url": "https://finnhub.io/api/news?id=26071c76c25a1bdffce7a09020cca095f0cfc5a5dbc5292e3e031d35f82698d9",
                "image": "",
                "source": "Fintel",
                "related": "SOLV",
                "summary": "",
                "category": "company",
                "datetime": 1787947900,
                "headline": "Solventum (SOLV) Price Target Increased by 10.88% to 95.90"
              },
              {
                "id": 141365587,
                "url": "https://finnhub.io/api/news?id=68ec63ea3407f00b7c5c4073a7a1c3cac4476c335afebb635ba07c026deeacd4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "Solventum’s 22% return over the past six months has outpaced the S&P 500 by 10.4%, and its stock price has climbed to $89.05 per share. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.",
                "category": "company",
                "datetime": 1787938372,
                "headline": "3 Reasons to Avoid SOLV and 1 Stock to Buy Instead"
              },
              {
                "id": 141365430,
                "url": "https://finnhub.io/api/news?id=61a03b449d5a885e39b6dbcae3a9e72871ea186a8e8c5a222ce1430ced2b10dc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are usually cheap for a reason, and a low valuation can reflect underlying business challenges rather than a genuine bargain.",
                "category": "company",
                "datetime": 1787923492,
                "headline": "3 Value Stocks with Open Questions"
              },
              {
                "id": 141314075,
                "url": "https://finnhub.io/api/news?id=cffee9de1f9c3c33dbc7f50b1cfc92908d0a7791b14fc63ba2cec5a04d3d6cb8",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1285071364/image_1285071364.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "SOLV",
                "summary": "Embecta (EMBC) looks like a deep value buy: P/E under 3x, 50%+ FCF yield, insider buying and rebound setup.",
                "category": "company",
                "datetime": 1787613074,
                "headline": "The Bottom Fishing Club - Embecta: Excellent Turnaround Prospect In Defensive Medical Products"
              },
              {
                "id": 141285779,
                "url": "https://finnhub.io/api/news?id=7c86e597ea1845610c6ae5afb3837269e13b54c7d0a294610c15eef5e61e207f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have returned 27.5% over the past six months, topping the S&P 500 by 16.2 percentage points.",
                "category": "company",
                "datetime": 1787234355,
                "headline": "1 Healthcare Stock for Long-Term Investors and 2 Facing Challenges"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 7,
            "negative_hits": 0,
            "positive_hits": 2,
            "recomputed_at_score": true,
            "sentiment_score_raw": 0.7,
            "source_article_count": 15,
            "discarded_article_count": 8
          },
          "sentimentPoints": 4
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 18.5,
        "grade": "一般",
        "items": {
          "bbPoints": 2.4,
          "adxPoints": 3,
          "sarPoints": 1.2000000000000002,
          "vcpPoints": 1,
          "macdPoints": 2.4,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 1,
            "vcp_reason": "跌縮量(近10日5日)；站上MA50；Ready=N；Confirm=N",
            "vcp_metrics": {
              "up_days": 2,
              "vol_ref": 1019403.3333333334,
              "down_days": 7,
              "vcp_ready": false,
              "above_ma50": true,
              "avg_vol_10": 865590,
              "avg_vol_20": 891480,
              "avg_vol_30": 1019403.3333333334,
              "range_pct_10": 0.08408374606033317,
              "range_pct_20": 0.08453399369653299,
              "range_pct_30": 0.14565511031067083,
              "up_expand_ok": false,
              "lookback_used": 59,
              "near_20d_high": true,
              "contraction_ok": false,
              "down_shrink_ok": true,
              "up_expand_days": 1,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 0.8491143512054437,
              "dist_to_20d_high": 0.05649957519116391,
              "down_shrink_days": 5,
              "breakout_level_20d": 94.16,
              "vcp_breakout_confirm": false,
              "contraction_ratio_10_30": 0.5772797527047914
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": false
          },
          "kdjAdxPoints": 0.7,
          "rsiKdjPoints": 2.4,
          "volumeWeight": 2,
          "maCrossPoints": 1.6,
          "shortRsiPoints": 0.8,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 1,
          "volumePointsTechnical": 1.6
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "一般",
        "items": {
          "position": {
            "score": 1.4,
            "details": {
              "atrPct": 2.6214542998649257,
              "turnoverUsdM": 205.79626088,
              "liquidityPoints": 0.4,
              "volatilityPoints": 1
            }
          },
          "rrPoints": 1.4,
          "stopLevels": {
            "symbol": "US.SOLV",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 84.1822,
            "strength_details": {
              "ma_score": 1.5,
              "atr_score": 2,
              "rsi_score": 1,
              "macd_score": 1.5,
              "volume_score": 3
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1.1,
            "stop_loss_percent": 5.2,
            "take_profit_price": 94.0761,
            "target_multiplier": 1.9,
            "technical_strength": 1.78,
            "take_profit_percent": 5.9
          },
          "positionPoints": 1.4,
          "stopLossPoints": 1.8,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.2,
          "stopLossPercent": 5.2429085997298515,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": true,
    "missingFields": [],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 85.71,
    "atr": {
      "atr": 2.3289,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 6,
      "atr_pct": 2.62
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "超買或超賣風險",
      "score": 2,
      "value": -108.54
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "派發",
      "score": 2,
      "value": -0.0308
    },
    "kdj": {
      "d": 31.34,
      "j": 33.98,
      "k": 32.22,
      "rule": "Cursor_18.24 K/D cross",
      "score": 4,
      "signal": "金叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "平衡",
      "score": 6,
      "value": 50.24
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 2,
      "trend": "資金流出",
      "value": 2257082,
      "recentSlope": -121401.8,
      "previousSlope": 15980
    },
    "rsi": 41.3,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 4,
      "trend": "下降",
      "value": 91.8936,
      "position": "SAR喺價上",
      "distancePct": 3.44,
      "previousTrend": "下降"
    },
    "ma50": 86.082,
    "macd": {
      "macd": 0.5667377080429077,
      "trend": "中性偏多",
      "signal": 1.133554823004609,
      "histogram": -0.5668171149617014
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 2,
      "value": 90.1643,
      "position": "<VWAP",
      "consecutiveAbove": 0
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "量價配合",
      "ratio": 2.4,
      "score": 8,
      "avgVolume": 967049,
      "currentVolume": 2316482
    },
    "derived": {
      "ma20": 90.2185,
      "ma50": 86.082,
      "prevClose": 87.53,
      "avgVolume10": 1018808,
      "avgVolume20": 967049,
      "changePercent": 1.5,
      "avgVolumeForScore": 967049
    },
    "ma_cross": {
      "ma20": 90.2185,
      "ma50": 86.082,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "多頭",
      "score": 4,
      "prevMa20": 90.207,
      "prevMa50": 85.8244,
      "spreadPct": 4.81,
      "isVolumeBreakout": true
    },
    "bollinger": {
      "lower": 87.2798,
      "upper": 93.1572,
      "position": "中間"
    },
    "rsi_short": 58.95,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 2.4
    }
  }
}

Raw metrics JSON

{
  "close": 88.84,
  "volume": 2316482,
  "changePercent": 1.5
}

Scores are derived from cached daily market data using the Cursor_18.25 standard. Solorank.ai provides research support only and does not provide financial advice or buy/sell recommendations.

US.SOLV · Solventum

避免

Score and price trend

Summary

Rolling setup rating

Has the score quality changed?

Signals

Full calculation detail

Market inputs

Metrics snapshot

110-point main rating

基本面 — 3.4/5 · 一般

Sub-items

資金流 — 6.8/20 · 較差

Sub-items

institutional

details

warning

市場環境 — 9.6/15 · 一般

Sub-items

vix

details

trend

details

qqq

spy

催化劑 — 6/20 · 較差

Sub-items

catalyst

details

風險管理 — 6.6/10 · 一般

Sub-items

position

details

stopLevels

strength_details

diversification

details

技術信號 — 18.5/30 · 一般

Sub-items

vcpPayload

vcp_metrics

情緒分析 — 4/10 · 較差

Sub-items

sentiment

details

sentimentData

Dimension contribution

5D momentum v2 breakdown

Risk management

position

details

stopLevels

strength_details

diversification

details

Calculation audit log

Technical indicators

Raw calculation JSON

Raw metrics JSON